Cevec Pharmaceuticals

Provider of glyco-optimised human cell lines and gene therapy vectors using proprietary cell expression system

placeCologne, North Rhine Westphalia, Germany calendar_todayFounded 2001 groups39 employees language cevec.com

Registered entities

Investor mix

30 investors on record.

Investor typeCountShare
Venture capital310%
Other / undisclosed2790%
Coming soon